D-0784-2016 Class II Terminated
FDA drug recall D-0784-2016 was initiated by Dr. Reddy's Laboratories, Inc. on Mar 3, 2016 and is designated Class II. Reason for recall: Lack of Assurance of Sterility; defective seals where the metal silver ring was not attached tightly to the vial The recall status is terminated (terminated May 3, 2017). Affected quantity: 3,342 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 6, 2016
- Initiation Date
- Mar 3, 2016
- Termination Date
- May 3, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,342 vials
Product description
Zoledronic Acid Injection, 5 mg/100 mL (0.05 mg/mL), 100 mL Single Use Bottle, Rx Only, Mfd. By: Gland Pharma Limited D.P. Pally - 500 043 INDIA NDC 55111-688-52
Reason for recall
Lack of Assurance of Sterility; defective seals where the metal silver ring was not attached tightly to the vial
Distribution pattern
Nationwide
Code information
Lot BS523, exp 10/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0784-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026